Bruker (NASDAQ:BRKR – Get Free Report) and Prenetics Global (NASDAQ:PRE – Get Free Report) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.
Insider and Institutional Ownership
79.5% of Bruker shares are held by institutional investors. Comparatively, 25.0% of Prenetics Global shares are held by institutional investors. 28.3% of Bruker shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Volatility and Risk
Bruker has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, Prenetics Global has a beta of -0.14, indicating that its stock price is 114% less volatile than the S&P 500.
Analyst Ratings
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Bruker | 1 | 2 | 6 | 0 | 2.56 |
Prenetics Global | 0 | 0 | 1 | 0 | 3.00 |
Bruker currently has a consensus price target of $85.00, suggesting a potential upside of 36.37%. Prenetics Global has a consensus price target of $9.00, suggesting a potential upside of 63.64%. Given Prenetics Global’s stronger consensus rating and higher probable upside, analysts plainly believe Prenetics Global is more favorable than Bruker.
Earnings and Valuation
This table compares Bruker and Prenetics Global’s revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Bruker | $2.96 billion | 3.06 | $427.20 million | $2.75 | 22.67 |
Prenetics Global | $21.74 million | 2.31 | -$62.72 million | ($4.45) | -1.24 |
Bruker has higher revenue and earnings than Prenetics Global. Prenetics Global is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Bruker and Prenetics Global’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Bruker | 13.38% | 27.31% | 8.82% |
Prenetics Global | -282.96% | -10.76% | -8.79% |
Summary
Bruker beats Prenetics Global on 12 of the 14 factors compared between the two stocks.
About Bruker
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
About Prenetics Global
Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.